European markets rebound, and BT might be in the sights of India’s Reliance

“Decisive action by governments to try and control the spread of the new Omicron Covid variant has restored some confidence among investors,” says Russ Mould,...

Mon, 29/11/2021 - 10:12


FTSE 100 starts week on front foot despite ongoing Omicron Covid variant worries

The FTSE 100 started Monday on the front foot, but gains were kept in check by ongoing worries about the omicron variant of Covid-19....

Mon, 29/11/2021 - 10:07


Tripe Point Income VCT sells 'substantial part' its hydroelectric power portfolio for £20.7m

Tripe Point Income VCT said it had sold a 'substantial part' of its hydroelectric power portfolio for about £20.7 million.

'The sale consisted of...

Mon, 29/11/2021 - 10:01


Gore Street Energy Storage Fund hails jump in capacity after Kilmannock asset wins increase grid allocation

Energy storage fund Gore Street Energy Storage Fund reported a capacity increase update for one of its Republic of Ireland assets that increased the overall...

Mon, 29/11/2021 - 09:53


Clinigen teams up with Nippon Shinyaku to launch managed access program for viltepso

Pharmaceutical services company Clinigen said it had signed an exclusive agreement with Nippon Shinyaku to implement a managed access program for viltepso, used to treat...

Mon, 29/11/2021 - 09:40


International Personal Finance swings to profit in first nine months of year

International Personal Finance swung to a profit in the first nine months of the year, as cost cuts offset a fall in revenue.

For the...

Mon, 29/11/2021 - 09:36


Aquila Services profits jumps in H1, led by higher revenue

Aquila Services reported a rise in profit in the first half of the year thanks to a rise in revenue.

For the six months...

Mon, 29/11/2021 - 09:32


Osirium Technologies sees revenue 'slightly behind' market expectations amid pandemic impact

Cybersecurity software company Osirium Technologies said it expected annual revenue to be 'slightly behind' current market expectations following the pandemic impact.

The company said...

Mon, 29/11/2021 - 09:17


Avacta's AVA6000 investigational new drug application receives approval in US

Biopharmaceutical company Avacta said the US Food and Drug Administration had approved its investigational new drug application for AVA6000.

This would allow the group...

Mon, 29/11/2021 - 08:42


Benchmark slashes annual losses as turnaround efforts take shape

Aquaculture biotechnology Company Benchmark reported narrower annual losses as its turnaround strategy continued to take shape.

For the year ended 30 September 2021, pre-tax...

Mon, 29/11/2021 - 08:34


Pages